Novartis AG
LSE:0QLR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novartis AG
LSE:0QLR
|
CH |
|
Ambev SA
BOVESPA:ABEV3
|
BR |
|
Huatai Securities Co Ltd
SSE:601688
|
CN |
Wall St Price Targets
0QLR Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for 0QLR is 123.65 CHF with a low forecast of 94.71 CHF and a high forecast of 145.1 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0QLR's stock price target?
Price Target
123.65
CHF
According to Wall Street analysts, the average 1-year price target for 0QLR is 123.65 CHF with a low forecast of 94.71 CHF and a high forecast of 145.1 CHF.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 4%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 5%.
